INTRODUCTION:
In 20-30% of breast tumors, ErbB2, a receptor tyrosine kinase (RTK) of the ErbB/EGFR family, is overexpressed (refs 1, 2, 3, 4) suggesting that molecules that downregulate the activity of this receptor kinase should act as efficient therapeutics in the management of breast cancers. Further, other members of the ErbB family, namely ErbB3 and ErbB4 have been implicated in the development of human breast cancers. Through our studies of the Drosophila homologue of ErbB RTK, we have discovered a transmembrane protein, named KekI, that acts as a negative regulator of the EGFR. Kekl (ref 5 ) is a member of a novel family of proteins and we have found that it is also a potent inhibitor of the EGFR in mammalian cells.
BODY:
In the previous application four specific aims were described to understand the regulatory mechanism by which Kek proteins inhibit the activity of members of the ErbB family of RTKs. We proposed to first determine precisely the molecular mechanism by which the Drosophila protein Kekl inhibits the activity of the Drosophila DER receptor. Second, we proposed to determine whether Kekl and its mammalian homologs inhibit the neoplastic state triggered by overexpression of the ErbB RTKs. Specifically, the goals were 1: We will define using the Drosophila system the molecular mechanism by which Kekl inhibits DER activity.
2: We will search for both murine and human Kekl homologs, examine their expression in mammary tissues and define their chromosomal locations.
3: We will determine whether Kek proteins can inhibit the activity of various mammalian ErbB RTKs in transformed cell lines.
4: We will test in transgenic mice whether Kek proteins can inhibit the occurence of ErbB-induced mammary carcinomas.
In the first year of the award, we have made significant progress towards the initial goals. Namely, we have completed aims 1 and 3. Three manuscripts, one publisked in Cell, and two additional ones which are almost completed, have resulted from this work. We have found that the Drosophila transmembrane molecule kekkon 1 (kekl) acts in a negative feed back loop to modulate the activity of the Epidermal Growth Factor Receptor (EGFR) tyrosine kinase. kekl is expressed in response to activation of the Gurken/EGFR signaling pathway during oogenesis. While loss of kekl activity is associated with a phenotype reminiscent of increased Grk/EGFR signaling, ectopic overexpression of kekl mimics the complete loss of EGFR activity. We found that the extracellular domain of Kekl physically associates with the EGFR providing the basis for this inhibitory mechanism. Interestingly, we found that Kekl is also a potent inhibitor of the EGFR in mammalian cells. Kekl binds the EGFR and related proteins ErbB2, ErbB3 and ErbB4. Kekl interferes with EGF mediated receptor tyrosine phosphorylation and activation of the downstream signaling molecules P13-kinase and Erk/MAP kinases. Kekl can also inhibit transformation in mouse mammary tumor cells with deregulated expression of receptors and ligands of the ErbB family.
In the second year of funding of the grant, we plan to initiate the projects relevant to aims 2 and 4 of the grant application.
KEY RESEARCH ACCOMPLISHMENTS:
We have shown that: 1. Kekl inhibits the activity of the Drosophila EGFR 2. the extracellular domain of Kekl physically associates with the EGFR providing the basis for this inhibitory mechanism. 3. Kekl is also a potent inhibitor of the EGFR in mammalian cells. First, Kekl binds the EGFR and related proteins ErbB2, ErbB3 and ErbB4. 4. Kekl interferes with EGF mediated receptor tyrosine phosphorylation and activation of the downstream signaling molecules P13-kinase and Erk/MAP kinases. 5. KekI can inhibit transformation in mouse mammary tumor cells with deregulated expression of receptors and ligands of the ErbB family.
CONCLUSIONS:
By examining how Kekl proteins are able to selectively block the activity of the ErbB family members, we may be able to design a novel strategy to control the development of breast cancers associated with misregulation of ErbB genes. Our studies on Kekl proteins may have two direct applications to breast cancer research. First, it may lead to the design of small molecule screens to identify compounds that mimic the effect of Kekl. Identification of such compounds may act as .efficient therapeutics against ErbB-induced cancers. Second, because we expect that human mutations in kekl homologs will be associated with upregulation of ErbB activity, it is possible that kekl genes will behave as tumor suppressors. Ultimately, diagnosis of kekl mutations could be performed to determine the predisposition of individuals to breast cancers.
REFERENCES:
1.
Slamon, D.J., Clark, G.M., Wong, S.G., Levin, W.J., Ullrich, A., and McGuire, W.L. (1987) . Human breast cancer: Corelation of relapse and survival with amplification of Her-2/neu oncogene. Science, 235:177-182.
2.
Slamon, D.J., Godolphin, W., Jones, L.A., Holt, J.A., Wong, S.G., Keith, D.E., Levy, W.J., Styart, S.G., Udove, J., Ullrich, A., and Press, M.F. (1989) . Studies of the Her-2/neu protooncogene in human breast and ovarian cancer. Science, 244:707-712.
3.
van de Vijver, M.J., van de Bersselaar, R., Devillee, C., Peterse, J., and Nusse, R. (1987) . Amplification of the neu(c-erbB-2) oncogenes in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol. Cell. Biol. 7:2019 -2023 
4.
Liu, E., Thor, A., He, M., Barcose, M., Ljung, B.M., and Benz, C. (1992) . The HER(c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. Oncogene, 7:1027-1032.
5.
Ghiglione, C., Carraway, K.L., Amundadottir, L.T., Boswell, R.E., Perrimon, N.*, and Duffy, J.B.* (1999). The transmembrane molecule Kekkon 1 acts in a feed back loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis.* Co-senior and corresponding authors. Cell 96. 847-856. naling activity have been characterized, only a few inhibitory molecules have been identified (Freeman et al., 1992; Kharitonenkov et al., 1997) . In addition to these inhibitory molecules, a number of inhibitory mechanisms Summary have been identified. These include internalization of
We have identified the Drosophila transmembrane ligand-receptor complexes, receptor desensitization as a result of hyperphosphorylation of the receptor, inmolecule kekkon 1 (kekl) as an inhibitor of the epiderhibitory regulation by cytoplasmic and transmembrane mal growth factor receptor (EGFR) and demonstrate that it acts in a negative feedback loop to modulate the protein phosphatases, and targeting to the proteolytic pathway of specific signal transducers (Ullrich and activity of the EGFR tyrosine kinase. During oogenesis, Schlessinger, 1990; Sturtevant et al., 1994 ; van der Geer kekl is expressed in response to the Gurken/EGFR et al., 1994; Kokel et al., 1998) . By integrating particular signaling pathway, and loss of kekl activity is associstimulatory and inhibitory mechanisms in cells, RTK acated with an increase in EGFR signaling. Consistent tivities can be quantitatively regulated to direct distinct with our loss-of-function studies, we demonstrate that cellular outcomes. ectopic overexpression of kekl mimics a loss of EGFR The Drosophila EGFR is required for a multitude of activity. We show that the extracellular and transmemdevelopmental processes throughout the life cycle (rebrane domains of Keki can inhibit and physically assoviews by Ray and Schupbach, 1996 ; Perrimon and Perciate with the EGFR, suggesting potential models for kins, 1997; Schweitzer and Shilo, 1997) . For example, this inhibitory mechanism.
activation of the EGFR pathway in follicle cells during oogenesis establishes both anteroposterior and dorsoventral fates. During embryogenesis, the EGFR is required Introduction for the establishment of ventral cell fates, determination of segmental identity, maintenance of amnioserosa and The biological processes regulated by receptor tyrosine ventral neuroectodermal cells, germband retraction, cell kinase (RTK) signaling pathways are diverse and include fate specification in the central nervous system, and the regulation of cell growth, differentiation, migration, production of cuticle. During larval development, the viability, and maintenance of homeostasis (see review EGFR plays a role in cell proliferation, vein formation, by Ullrich and Schlessinger, 1990) . In the past few years, and eye development. These multiple tissue-specific aca great deal has been learned about the mechanisms tivities are regulated in part by different ligands that conby which RTKs transduce signals and specify particular tain an EGF repeat similar to that of transforming growth cellular fates. In particular, most RTKs have been shown factor u. (TGFoa), a known ligand of the vertebrate EGFR. to regulate gene expression through the Ras/Raf/MEK/ To date, three such ligands have been isolated in Dro-MAPK cassette (see Li and Perrimon, 1997 Schnepp et al., 1996) . In conabout the mechanisms involved in imparting specificity.
trast to these stimulatory molecules, Argos (Aos), a seMore recently, however, it has been shown that modulacreted protein with an atypical EGF motif, has been tion of RTK activities is a critical aspect of their biological shown to act as an antagonist of EGFR activity (Schweitzer et al., 1995b) . In vitro studies have revealed that Aos can interfere with EGFR activation in a manner that is 5 To whom correspondence should be addressed (e-mail: perrimon@ both saturable and competitive, and it has been pro- Present address: deCode Genetics, Lynghals 1, 110 Reykjavik, posed that Aos acts as a direct inhibitor of Spi by binding Iceland. directly to the EGFR (Schweitzer et al., 1995b (Brand and Perrimon, 1994; Hsu and Perrimon, 1994; Schnorr E F and Berg, 1996) . In a screen to identify downstream genes regulated by the EGFR in follicle cells, we have identified the gene kekkon 1 (kekl), which encodes a single pass transmembrane protein with features of a cell adhesion molecule with leucine-rich repeats (LRR) and immunoglobulin (Ig) To characterize target genes of the EGFR signaling pathof the EGFR receptor pathway using the gain-of-function Draf gene way, we screened a collection of enhancer trap lines for hsDraf-F 2 2 (F) leads to uniform kek-lacZ expression. Induction of WT Draf during oogenesis had no effect on the expression of kekexpression patterns in follicle cells. We found one line, lacZ (not shown). 15A6, which was expressed in a pattern consistent with (G and H) The position of the oocyte nucleus defines the spatial it being a regulatory target of the EGFR pathway, since domain of kekl expression. In response to colchicine treatment, the it undergoes a transition during stages 8-10 when it o~ocyte nucleus and its associated grk mRNAs become misplaced relocalizes from a posterior to a dorsal-anterior gradient during o~og~en~esis (G and H). In these egg chambers, the expression ( Figures 1A-lC) . 15A6 corresponds to an insertion in of kek-lacZ can be detected posteriorly as well as ventrally. In (G) and (H), the g~ermline nuclei are marked with the enhancer trap line the kekl gene (Musacchio and Perrimon, 1996) , and we es(3)79 to allow easy detection of the oocyte nucleus (indicated by refer to it as kek-lacZ in the text. We found that kekthe arrows). lacZ expression reflects accurately the expression of (C-H) are stage 10 egg chambers oriented with dorsal up. Anterior kekl both in wild-type (WT) and in mutant backgrounds is to the left in all panels. (data not shown).
To establish a regulatory link between the transcripet al. , 1997; Sapir et al., 1998) , revealing that kek-/acZ tional regulation of kekl in the follicle cell epithelium expression is transcriptionally regulated by the Grk/ and the Grk/EGFR signaling pathway, we examined kek-EGFR/Draf pathway. Expression of an activated form of lacZ expression in mutants for grk, egfr, and the kinase Draf resulted in the ubiquitous expression of kek-lacZ Draf that is both necessary and sufficient for EGFR sigwithin the follicular epithelium (Figure 1 F) . naling in follicle cells (Brand and Perrimon, 1994) . In
To further analyze the role of the Grk/EGFR pathway each case, the dorsal-anterior gradient of kek-lacZ exin the transcriptional control of kek-lacZ, we mislocalpression was abolished or severely diminished (Figures ized the subcellular localization of grk mRNAs by dis-1D and 1 E; see also Brand and Perrimon, 1994 ; Queenan rupting the oocyte cytoskeletal network ( Figure 1G ). Figure A2 ), as observed in embryos derived from grk homozygous 3 B mothers (Roth and Schupbach, 1994) . This
=II.
ventralization phenotype can be readily detected using the Twi marker for ventral cell fates. In W'T embryos (A3 and A4), Twi is expressed in the ventral-most region of the em-B4 : C4
bryo. The Twi expression domain is enlarged when either kekl or the egfrDN is misexpressed (B3, B4, C3, C4).
In all panels, anterior is to the left. The chorions shown in (Al), (B1), and (Cl) are dorsal views. The embryos in (A2), (B2), (C2), (A3), (B3), (W3), and (A4), (B4), and (C4) are lateral and ventral views, respectively.
Treatment of the oocyte with colchicine, an inhibitor of In addition to its role in establishing the dorsal characmicrotubule polymerization, leads to mislocalization of teristics of the eggshell, the Grk/EGFR pathway controls the oocyte nucleus and its associated grk mRNAs, which embryonic dorsoventral patterning by restricting a vencorrelated with ectopic kek-lacZ expression (Figure 1 H) tralizing signal (Neuman-Silberberg and Schupbach, as well as kekl mRNA expression (not shown). Alto-1994; Morisato and Anderson, 1995) . As a result, loss of gether, these results demonstrate that Grk is not only EGFR function leads to ventralized embryos. Embryonic necessary but sufficient to regulate the spatial exprescuticles derived from T155; UAS-kekl females showed sion of kekl. a ventralized cuticle phenotype ( Figure 2B2 ). To analyze the extent of this ventralization, we stained embryos for Overexpression of kekl during Oogenesis Twist (Twi) RNA and protein that label a ventral domain Antagonizes EGFR Activity ten cells wide (Thisse et al., 1988) . Overexpression of Previous analysis has revealed that in the complete abkekl in follicle cells results in an expansion of the Twi sence of kekl gene activity, flies are viable, fertile, and expression domain (Figures 2B3 and 2B4) . Similarly, emdo not exhibit any overt morphological defects (Musacbryos derived from T155; UAS-egfrDN females are also chio and . Kekl has the features of cell strongly ventralized ( Figures 2C2-2C4 ). adhesion molecules (CAMs), and loss-of-function mutaAltogether, our results indicate that overexpression tions of many CAMs have subtle mutant phenotypes.
of kekl in follicle cells ventralizes both the eggshell and However, when ectopically overexpressed, some CAM the embryo by most likely interfering with the activity of molecules can generate striking mutant phenotypes that the Grk/EGFR signaling pathway. are revealing of their functions (Speicher et al., 1998) . Thus, to gain insights into the possible function of kekl Kekl Inhibits the Activity of during oogenesis, we tested the effect of overexpressthe Ras/Raf/MEK/MAPK Cassette ing kekl in the follicle cells using the GAL4/UAS system To determine whether Kekl blocks the signaling activity (Brand and Perrimon, 1993) .
of the EGFR, we tested whether ectopic expression of When kekl is expressed under the control of the GAL4 kekl blocks the transcriptional activation of target genes line T155, which drives expression all over the follicle regulated by the EGFR/Ras/Raf/MEK/MAPK pathway in cell epithelium beginning at stage 9 (Harrison et al., 1995;  follicle cells. Since kekl is a target of this pathway, we Queenan et al., 1997), 100% of the resulting eggs are used kek-lacZ as a reporter for this experiment. Overexlonger than the WT eggs and have a reduction or a pression of kekl using the Gal4 driver T1 55 was associcomplete loss of dorsal appendages (cf. Figure 2B1 with ated with a strong but not complete reduction of kekthe WT in Figure 2A1 ). This loss of dorsal appendage lacZ expression (cf. Figure 3B to WT in Figure 3A ). Using material is due to a ventralization of the eggshell, a a stronger Gal4 line, CY2 (Queenan et al., 1997), a comphenotype associated with egfr, or grk loss-of-function plete disappearance of kek-lacZ expression was obmutations (Schupbach, 1987; Price et al., 1989) . A similar served ( Figure 3C ). These data are consistent with the ventralized eggshell phenotype was obtained when a model that Kekl downregulates the activity of the Ras/ dominant-negative form of the EGFR, EGFRDN, was Raf/MEK/MAPK pathway. Consistent with this, epistasis expressed under the control of T155 ( Figure 2C1) . experiments indicate that the inhibitory effect of Kekl ventralization phenotype of UAS-kekl (Figure 4) (Musacchio and Perrimon, 199, 6) , is required for the inhibition of the EGFR activity by Kekl, we generated transgenic lines that contain either UAS-kekl" la or UAS-kekl1lla.
4x
•No phenotype were observed by overexpressing kekVnt'a (data not shown) in the follicle cells using the SA T1 55 or CY2 GAL4 lines. On the other hand, overexpression of keklr using the same drivers led to eggs with reduced dorsal appendage materials ( Figure 5A ) and as when multiple copies of the transgenes were added. This suggests that Kekl xtra is less stable than the fulllength Kekl molecule or that the cytoplasmic domain is overridden by the constitutive activation of the EGFR of Kekl participates to some extent in the inhibition. or Draf (Figure 4) . In addition, we tested the interaction Finally, we tested whether the inhibition of the EGFR between the transmembrane protein Rhomboid (Rho) activity by kekloxtr requires the presence of the endogeand Kekl. Rho has been proposed to play a role in nous Kekl protein. When kek10' was overexpressed the activation of the EGFR (Schweitzer et al., 1995a;  inkekl mutant females, the eggs were ventralized, which Golembo et al., 1996a) , and overexpression of Rho leads excludes a model whereby keklextra blocks the EGFR to dorsalized eggshells (Ruohola-Baker et al., 1993) . We by forming a heterodimer with the endogenous Kekl find that overexpression of rho does not override the protein (data not shown). ; this study, data not shown). We found that eggs laid by females carrying one copy of P [grk] in the absence of kekl are significantly dorsalized (Figure 6B1) : the spacing between the dorsal appendages is increased and the eggs are rounder and smaller. Further, Twi expression that is normally expressed in embryos laid by females carrying one copy of P [grk] (n = 168; data not shown) is repressed ventrally in 15% (n = 181) of the embryos derived from kekl mutant females that carry a single copy of P [grk] . When raised at 29°C, 22% (n = 348) of the embryos derived from eggs laid by females carrying one copy of P [grk] (Schupbach, 1987) . They exhibit either no oronly a single Signaling Pathway dorsal appendage, and the eggs are significantly longer Because of the severe inhibition of EGFR activity by than WT (100%, n = 852; Figures 6C1 and 6C2 ). In Kekl revealed by the overexpression experiment, we contrast, the majority of eggs (95.5%, n = 1103) laid by decided to reexamine the effect of loss of kekl function the kekl-egfr-double mutant females have two dorsal during oogenesis. We reasoned that a subtle egg morappendages and their length is shorter, consistent with phology phenotype may have been missed by simply a reversion to a more WT phenotype ( Figure 6C3 ). using fertility as an assay (Musacchio and Perrimon, 1996) . Indeed, we found that the spacing between the Kekl Physically Associates with the EGFR dorsal appendages of eggs derived from kekl mutant Having demonstrated that the in vivo role of kekl is females was increased when compared to WT. Further, consistent with the results obtained by overexpression, these eggs were also mildly shorter and rounder ( Figure  we wanted to gain insight into the mechanism of inhibi-6A1), a phenotype consistent with a hyperactivation of tion of the EGFR by Kekl. To do so, we tested whether the Grk/EGFR pathway (Neuman-Silberberg and Schup-EGFR and Kekl physically associate. Following coexbach, 1994). These features do 'not interfere with hatchpression of a Myc-tagged version of Kekl and the EGFR ing rates and patterning that is consistent with the noror the Drosophila Torso RTK in Sf9 cells, Kekl was mal Twi expression found in kekl mutant embryos (n = immunoprecipitated from the cell lysates using an anti-142). Interestingly, when kekl mutant flies were raised Myc antibody. Coprecipitation of the EGFR was obat 290C, 5% (n = 257) of the embryos derived from served by probing the resulting blot with the anti-EGFR kekl mutant females showed a mild reduction in Twi antibody ( Figure 7A ), suggesting that Kekl associates expression ( Figures 6A2 and 6A3) . We conclude that physically with the EGFR and that this interaction is loss of kekl activity during oogenesis leads to mildly responsible for the inhibitory effect. When both Kekl dorsalized eggs.
and Torso were coexpressed in Sf9 cells, no Torso was To substantiate the functional relationship between coprecipitated by Kekl ( Figure 7A ), suggesting a selecKekl and the Grk/EGFR signaling pathway during ootivity of Kekl for binding to the EGFR. genesis, we examined the effects of a loss of Kekl Because the extracellular and transmembrane poractivity in two different genetic backgrounds. First we tions of Kekl are essential for the inhibitory effect, we tested if an increase in the level of Grk molecules can examined whether these portions of Kekl are able to generate a stronger phenotype in the absence of kekl. bind to the EGFR. As shown in Figure 7B , the extracelluPreviously, Neuman-Silberberg and lar domain, but not the intracellular domain, of Kekl can showed that females carrying four copies of a transgene bind to the EGFR. Thus, we propose that the inhibitory expressing grk (P[grk] ), in addition to the two endogeeffect of the EGFR by Kekl is mediated through direct nous copies, lay a significant fraction of partially or seassociation of the extracellular and transmembrane doverely dorsalized eggs. In contrast, females that carry mains of Kekl with the EGFR. Figure 6A1 with a WT eggshell shown in Figure  2AM ). By increasing the temperature, we observed a weak enhancement of both the eggshell and the embryonic phenotypes readily detectable by aberrant Twi expression ( Figures 6A2 and 6A3 ).
(B1-B3) The dorsalization phenotype associated with loss of kekl function is enhanced by an increase in the level of Grk li~gan'd. The eggs derived from kekl mutant females that contain an extra copy of grk, provided by a P[grk] transgene, showed an enhancement of the dorsalized eggshell phenotype (cf. Figure 6B1 with Figure 6A1) , and the embryos derived from these eggs showed a stronger dorsalized phenotype (cf. Figures 6B2 and 6B3 with Figures 6A2 and 6A3) . Orientations are the same as in Figure 2 . 7 . In addition to the recovery of the two dorsal appendages, the length of the chorion has also become similar in length to WT.
Discussion
The Function of Kekl in Patterning of the Follicle Cell Epithelium We have identified the transmembrane protein Kekl as During oogenesis, Grk derived from the oocyte activates a molecule that acts in a negative feedback loop to in a paracrine fashion the EGFR in dorsal follicle cells. modulate the activity of the Drosophila EGFR tyrosine Recent work from Wasserman and Freeman (1998) has kinase during oogenesis. We provide loss-of-function, shown that this paracrine signaling leads to the activaectopic overexpression, and biochemical evidence to tion of a second phase of signaling, whereby the EGFR support this. First, eggs laid by females that lack kekl activity is amplified among follicle cells themselves. Durgene activity are weakly dorsalized, and loss of kekl ing this second phase, the EGFR activates a number of gene activity can suppress egfr mutations and potentitarget genes that include both positive (rho and vn) and ate Grk signaling. Second, ectopic overexpression of negative (aos) regulators of the pathway. Activation of Kekl in follicle cells leads to severe ventralization identiRho in follicle cells presumably leads to the activation cal to effects seen in EGFR mutants, providing further of the Spi EGFR ligand, while activation of Aos within support of Kekl as a negative regulator of the EGFR the peak of EGFR activity at the dorsal anterior leads pathway. Finally, we provide biochemical evidence that to repression of EGFR, effectively splitting the initial the inhibition of EGFR activity by Kekl involves the direct peak of EGFR activity into two. This splitting of EGFR association between the extracellular and transmemactivity eventually defines the domains where the dorsal brane domains of Keklb and the EGFR. appendages will form. Our identification of Kekl, together with the studies Interestingly, kekl is expressed in the eye and wing on Aos, indicates that there are at least two different imaginal discs in a pattern that is highly suggestive of negative regulators of EGFR activity in follicle cells. induction by the EGFR (Musacchio and Perrimon, 1996) .
However, the regulation and function of Kekl is distinct Although no obvious phenotypes have been described from those of Aos. aos is expressed only in response in these tissues in kekl mutants, we found that overexto high levels of EGFR activity, while kekl is expressed pression of kekl in these tissues also generate phenoin a graded fashion. Further, loss-of-function phenotypes reminiscent to loss of EGFR activity (not shown).
types of kekl and aos in follicle cells are different. In This suggests that the negative regulation of the EGFR the absence of kekl activity, the spacing between the by Kekl is not only restricted to oogenesis.
dorsal appendages is increased, while in the absence
A"
Further, we have shown that the extracellular and trans- Kaech et al., 1998) . Interestingly, we note that Antibodies both Kekl and the EGFR contain a TXV motif at the 47-1 C terminus. This S/TXV motif has been implicated in protein-protein interactions and suggests that Kekl Figure 7 . Association of Kekl with the Drosophila EGFR and/or the EGFR may interact with PDZ-containing pro-(A) Lysates from Sf9 insect cells expressing the Drosophila EGFR teins (Songyang et al., 1997 ; see reviews by Kim, 1997 or Torso, or Kekl -Myc (kek) Kekl extra is less stable than the full Kekl molecule or that (lower panels). In Sf9 cells, the EGFR migrates at two prominent the cytoplasmic domain of Kekl participates to some forms. The lower EGFR band probably represents an underglycosyextent in the inhibition. Possibly, Kekl is targeted to a lated form of the receptor. We noted that at higher Kekl expression subcellular region within the cells where the EGFR itself levels binding to Torso was also observed (not shown), perhaps is located. This model would explain why unlocalized reflecting some degree of stickiness of the Kekl protein.
Kekl extr would be less efficient at inhibiting EGFR activ-(B) Sf9 cells were infected with baculovirus encoding the Drosophila EGFR and coinfected with nothing (None) or viruses encoding Mycity than the full-length Kekl molecule. tagged versions of full-length Kekl (kek), a form encompassing the transmembrane and the extracellular domains of Kekl (kek ECD), An Emerging Theme in Patterning Mechanisms and a form encoding the intracellular domain of Kekl fused to a Kekl identifies a novel member of a growing class of v-Src myristylation site (kek ICD). Anti-Myc immunoprecipitates negative regulators that are positively transcriptionally were blotted with anti-EGFR (left panel) and then reprobed with anti-Myc (right panel). Note that the 55 kDa Kekl intracellular domain regulated by the pathway that they inhibit. As discussed is hidden in the Myc immunoprecipitate by the heavy chain of the in the Introduction, the secreted molecule Aos acts in precipitating antibody, but it has been detected in the lysates.
a feedback loop to downregulate in a paracrine fashion the activity of the EGFR, possibly by preventing the mechanism of activation of the receptor by the Spi ligand of aos, the appendages are fused dorsally. Aos has been (Schweitzer et al., 1995b; Golembo et al., 1996b ). Anproposed to split the initial peak of EGFR activity into other inhibitor of an RTK pathway is Sprouty, which two (Wasserman and Freeman, 1998) . We propose that antagonizes the activity of the FGF receptor Breathless the function of Kekl is to restrict the lateral spreading (Btl) and is transcriptionally controlled by activated Btl of EGFR activation by Spi. Thus, in the absence of kekl (Hacohen et al., 1998) . activity, Rho/Spi activation could spread more laterally, It is worth noting, however, that not all secreted negaexplaining the enhancement of the spacing between the tive regulators of specific signaling pathways work in two dorsal appendages.
negative feedback loops. These include Chordin/SOG (Piccolo et al., 1997) and Noggin (Zimmerman et al., 1996) , which antagonize signaling by TGF-P3 family memMechanism of Inhibition of the EGFR by Kekl bers; FrzB proteins, which encode secreted proteins Our analysis demonstrates that Kekl acts as a potent with sequence homologies to the extracellular cysteinenegative regulator of EGFR activity when overexpressed. Brand and Perrimon (1994) . The UAS-EGFRDN is described in Freeman (1996) . The enhancer trap line es(3)79, the Smad7, which is expressed in response to TGF-)3 signal-P [grk] , and the UAS-Xtop (Queenan et al., 1997) flies were a gift ing, blocks the activity of this pathway intracellularly by from T. Schupbach.
binding to the TGF-P3 receptor and by inhibiting Smad2 Ectopic expression in the follicular epithelium was performed with and Smad3 phosphorylation that is required for transthe pGawB GAL4 linesT1 55 (Harrison et al., 1995) and CY2 (Queenan duction of the signal (Nakao et al., 1997) . Another examet al., 19'97) .
pie is the human CL100 phosphatase that after being expressed following exposure to either oxidative stress Inhibitor Studies or heat shock downregulates specifically the MAP kiThe colchicine inhibitor was used at 25 or 50 iig/ml to destabilize microtub~ules as described in Theurkauf et al. (1993) . As a control, nase (Keyse and Emslie, 1992) . The Drosophila homolog flies were treated with 50 9g/ml of )3-lumicolchicine, which is an of CL1 00, known as puckered, has been shown to mediinactive isomer of colchicine. (our unpublished data). The function of these additional Kek-like proteins is not known. However, it is interesting
In Situ Hybridization and I-Galactosidase Histochemistry to note that despite extensive saturation of the region
In situ hybridization was performed with digoxigenin-labeled grk, containing kek3, no mutant alleles have been recovered kekl, and twist RNA essentially as described in Tautz and Pfeifle (Ashburner et al., 1990; Spradling et al., 1995; our unpub-(1989) using 55°C and 65°C as the hybridization temperature.
For detection of 03-galactosidase activity, ovaries were dissected lished data). Whether or not this and the subtle effect in PBT (PBS + 0.1% Tween 20) and fixed in 4% methanol-free of loss of Kekl activity is due to redundancy within the formaldehyde for 15 min or in 2.5% glutaradehyde for 2.5 min. OvaKekkon family remains to be determined. Thus, it will ries were then stained with 1 mg/ml X-Gal in X-Gal staining buffer be important to characterize the expression patterns as at 25°C for 3.5-4.5 hr.
well as the loss-of-function and overexpresssion phenoThe polyclonal rabbit anti-Twist antibody (Roth et al., 1989 ) was types of kek2 and kek3 in order to evaluate any potential used at a dilution of 1:5000.
For visualization, embryos and egg chambers were directly abilities to modulate the EGFR activity. Further, chimeric mounted in 80% glycerol and photographed under Nomarski optics proteins between these molecules may help to further with a Zeiss Axiophot microscope. Embryonic cuticles and chorions define the Kekl domain(s) required for the inhibitory were prepared according to van der Meer (1977) and visualized mechanism.
using dark-field optics.
Finally, we note that there are putative transmembrane proteins in vertebrates (Suzuki et al., 199, 6) and Constructs invertebrates that show similar arrangements of LRRs UAS-kekl was made in the following manner. A Hindlil/EcoRI fragand Ig motifs. This raises the possibility that Kekl is a ment from the kekl cDNA containing the complete coding region (Musacchio and Perrimon, 1996) was subcloned into pBSKm. From member of a family of structurally related EGFR inhibithis subclone, an Xbal/Xhol fragment containing the complete kekl tors. As alteration in the activity of the various members coding region was cloned into the P element vector pUAST (Brand of the human EGFR/ErbB family has strong links to onand Perrimon, 1993). UAS-keklr was made by inserting by PCR cogenesis, it will be important to determine if vertebrate a stop codon immediately after the transmembrane domain of kekl LRR/Ig molecules share functional, in addition to seand UAS kekll by fusing a v-Src myristylation site to the entire quence, similarities to Kekl. We anticipate that the conintracellular domain of kekl. P element-mediated transformation was performed following injection into the delta 2-3 transposase tinued characterization of the Kek and related molecules strain (Robertson et al., 1988) .
will provide novel approaches to the design of inhibitors of the EGFR/ErbB family for therapeutic use in oncoInsect Cell Experiments genesis.
cDNAs encoding the Drosophila EGFR and myc-tagged versions at the C terminus of full-length kekl, kekl' a, and keklint'r were Experimental Procedures subcloned into the baculovirus transfer vectors pVL1392 or pVL1393 (Pharmingen).
Fly Stocks
Recombinant baculoviruses were produced in Sf9 insect cells Various collections of enhancertrap lines were screened for expresusing the Bac-N-Blue transfection kit (Invitrogen) and plaque purision patterns within the follicular epithelium (Perrimon et al., 1991;  fied prior to use. For coexpression experiments, 107 Sf9 cells were Smith et al., 1993; D. Eberl, unpublished) . From this screen, the infected at a multiplicity of infection of 30. For the EGFR/Torso second chromosomal enhancer trap line 15A6 was identified. For a comparison experiment, cells were infected with a 1:1:28 ratio of description of 15A6, which we refer to as kek-lacZ, see Musacchio Drosophila EGFR:Kekl:WT baculovirus. For the domain deletion and Perrimon (1996) . The two overlapping deficiencies, RA5 and experiment, cells were infected with a 10:20 ratio of EGFR:Kekl RM2, completely delete the kekl gene (Musacchio and Perrimon, virus. For both experiments, cells were infected for 48 hr and then 1996), and we refer to RA5/RM2 females as kekl mutant females lysed in 1 ml 20 mM HEPES/Na, 150 mM Nacl, 1mM EDTA, 10% NPin this paper.
40, 1 mM PMSF, and 1 mg/ml each of p~epstatin A, aprotinin, and The alleles of the egfr, egfr 0 QY, egfrcJ, egfr' 01 , egfr 2 E°7 are described leupeptin. Cleared lysates were immunoprecipitated with 1 Vg antiin Clifford and Schupbach (1989) . For a description of grk < 3 1, see
Myc (Ab2, NeoMarkers). Precipitates were washed three times with Schupbach (1987) and Neuman-Silberberg and Schupbach (1993) . lysis buffer, resolved by 6% SDS-PAGE, and blotted with 1/5000
anti-EGFR or 1/5000 anti-Torso. Filters were then stripped and reKharitonenkov, A., Chen, Z., Sures, I., Wang, H., Schilling, J., and probed with 1/200 anti-Myc. UlIrich, A.-(1997) . A family of proteins that inhibit signaling through tyrosine kinase receptors. Nature 386, 181-186.
